160 related articles for article (PubMed ID: 7681493)
1. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
Potter EK; Edvinsson L; Gustafsson T
Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
[TBL] [Abstract][Full Text] [Related]
4. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
Pernow J; Modin A; Lundberg JM
Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
7. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
9. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP).
Wahlestedt C; Reis DJ; Yoo H; Adamsson M; Andersson D; Edvinsson L
Neurosci Lett; 1992 Aug; 143(1-2):123-6. PubMed ID: 1436655
[TBL] [Abstract][Full Text] [Related]
10. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
Sun XY; Edvinsson L; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
Pernow J; Kahan T; Lundberg JM
Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
[TBL] [Abstract][Full Text] [Related]
12. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
Sun XY; Dahlöf C; Edvinsson L; Hedner T
Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
Adamsson M; Fallgren B; Edvinsson L
Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
15. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
Edvinsson L; Adamsson M; Jansen I
Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
[TBL] [Abstract][Full Text] [Related]
17. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
Adamsson M; Edvinsson L
Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
[TBL] [Abstract][Full Text] [Related]
18. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
Heilig M; Edvinsson L; Wahlestedt C
Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
[TBL] [Abstract][Full Text] [Related]
20. Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release.
Pernow J; Schwieler J; Kahan T; Hjemdahl P; Oberle J; Wallin BG; Lundberg JM
Am J Physiol; 1989 Sep; 257(3 Pt 2):H866-72. PubMed ID: 2782443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
